Shailja Tiwari is a business journalist at Financial Express, writing primarily for BrandWagon. She covers branding, marketing, and the business of healthcare, with occasional deep dives into pharma, healthtech, and diagnostics. Her work focuses on unpacking industry trends, consumer behaviour, and regulatory shifts through sharp reporting and data-driven analysis.
Nectar to sell API, formulations & menthol biz to Ceph Lifesciences for Rs 1,290 cr
Nectar Lifesciences Ltd on Tuesday said it will sell its active pharmaceutical ingredients and formulation along with menthol business assets to Ceph Lifesciences Pvt Ltd, for Rs 1,290 crore.
India’s Healthcare Crossroads: Is Innovation Enough Without Investment?
India’s healthcare sits at a crossroads—rich in tech innovation but starved of system-wide investment. Coverage is growing, but care still lags. Can we fix systems, not just symptoms?
Fixing Healthcare in India Will Take More Than Just Technology
Experts building India’s future-ready healthcare demands more than apps—it needs smart policy, investment, community skilling, and digital tools
India’s Drug Regulator Wants the World to Rethink Its Assumptions
From stricter standards to cutting-edge therapies, DCGI Dr. Rajeev Singh Raghuvanshi outlines how India is repositioning itself as a global pharmaceutical force.
Empower your business. Get practical tips, market insights, and growth strategies delivered to your inbox
By continuing you agree to our Privacy Policy & Terms & Conditions
